Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases.
Pires da Silva I, Li I, Ugurel S, Serra-Bellver P, Andhale A, Burnette H, Aya F, Conway JW, Braden J, Carlino MS, Menzies AM, Weichenthal M, Mohr P, Gutzmer R, Arance AM, Johnson DB, Lorigan P, Schadendorf D, Lo SN, Long GV.
Pires da Silva I, et al.
Eur J Cancer. 2024 May 7;205:114101. doi: 10.1016/j.ejca.2024.114101. Online ahead of print.
Eur J Cancer. 2024.
PMID: 38735161